Brain development and the onset of depression in youth

大脑发育和青少年抑郁症的发病

基本信息

  • 批准号:
    444380
  • 负责人:
  • 金额:
    $ 79.42万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Operating Grants
  • 财政年份:
    2021
  • 资助国家:
    加拿大
  • 起止时间:
    2021-04-01 至 2026-04-01
  • 项目状态:
    未结题

项目摘要

Depression is one of the most common and disabling human health problems worldwide. Depression most often starts in adolescence or in early adulthood, at a time when a rapid phase of brain development is culminating. Mapping brain development through adol
抑郁症是世界范围内最常见和致残的人类健康问题之一。抑郁症通常始于青春期或成年早期,此时大脑发育的快速阶段达到顶峰。通过adol绘制大脑发育图

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Uher Rudolf其他文献

Uher Rudolf的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Uher Rudolf', 18)}}的其他基金

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
单相重度抑郁症药物的优化预测治疗 (OPTIMUM-D)
  • 批准号:
    469292
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Impact of the COVID-19 pandemic on mental health of children of parents living with mental illness
COVID-19 大流行对父母患有精神疾病的儿童心理健康的影响
  • 批准号:
    450651
  • 财政年份:
    2021
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Brain development and the onset of depression in youth
大脑发育和青少年抑郁症的发病
  • 批准号:
    432009
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Impact of the COVID-19 pandemic on Canadians living with mental illness, and their children
COVID-19 大流行对患有精神疾病的加拿大人及其子女的影响
  • 批准号:
    430402
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Canada Research Chairs - Tier 1
加拿大研究主席 - 第一级
  • 批准号:
    441802
  • 财政年份:
    2020
  • 资助金额:
    $ 79.42万
  • 项目类别:
Automated analysis of natural speech in personalized treatment for major depressive disorder
重度抑郁症个性化治疗中自然语音的自动分析
  • 批准号:
    402797
  • 财政年份:
    2019
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Sleep and circadian rhythm as developmental antecedents to major mood disorders
睡眠和昼夜节律是主要情绪障碍的发展前因
  • 批准号:
    409595
  • 财政年份:
    2019
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
CRC Tier 2
CRC 2 级
  • 批准号:
    364820
  • 财政年份:
    2016
  • 资助金额:
    $ 79.42万
  • 项目类别:
Families Overcoming Risks and Building Opportunities for Well-being (FORBOW): Early Intervention Targets Psychopathological Antecedents to Pre-empt Severe Mental Illness in Youth at Risk
家庭克服风险并创造幸福机会(FORBOW):早期干预针对精神病理学前因,以预防高危青少年的严重精神疾病
  • 批准号:
    333765
  • 财政年份:
    2015
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Families Overcoming Risks and Building Opportunities for Well-being (FORBOW): evaluating pre-emptive early interventions for antecedents to prevent severe mental illness
家庭克服风险并创造福祉机会(FORBOW):评估先发制人的早期干预措施,以预防严重的精神疾病
  • 批准号:
    332982
  • 财政年份:
    2015
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants

相似海外基金

Zebrafish models of Major Depressive Disorder as a replacement for rodent models
重度抑郁症斑马鱼模型替代啮齿动物模型
  • 批准号:
    NC/X001520/1
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Training Grant
Integrating 1H MRS with 2H-Labeled Glucose to Characterize Dynamic Glutamate Metabolism in Major Depressive Disorder
将 1H MRS 与 2H 标记的葡萄糖相结合来表征重度抑郁症的动态谷氨酸代谢
  • 批准号:
    10668075
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
2/2 Large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder
2/2 重度抑郁症情绪调节回路的分子和细胞网络的大规模单细胞表征
  • 批准号:
    10745412
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
Scalable Biomarkers And Time-Series Microsignatures Of Relapse In Major Depressive Disorder
重度抑郁症复发的可扩展生物标志物和时间序列微特征
  • 批准号:
    490461
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
Novel markers for tracking early treatment response to rTMS in major depressive disorder
用于追踪重度抑郁症 rTMS 早期治疗反应的新标记
  • 批准号:
    488406
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Operating Grants
1/2 Large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder
1/2 重度抑郁症情绪调节回路的分子和细胞网络的大规模单细胞表征
  • 批准号:
    10744931
  • 财政年份:
    2023
  • 资助金额:
    $ 79.42万
  • 项目类别:
Individualized Functional Targets for Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: Does Targeting sgACC-DLPFC Connectivity Lead to Better Outcomes?
经颅磁刺激治疗重度抑郁症的个体化功能目标:以 sgACC-DLPFC 连接为目标是否会带来更好的结果?
  • 批准号:
    474509
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
    Studentship Programs
Improving the interpretability of genetic studies of major depressive disorder to identify risk genes
提高重度抑郁症基因研究的可解释性以识别风险基因
  • 批准号:
    10504696
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
Evaluating Contributors to Relapse in Comorbid Major Depressive Disorder and Cannabis Use Disorder
评估共病重度抑郁症和大麻使用障碍复发的因素
  • 批准号:
    10640111
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
Improving the interpretability of genetic studies of major depressive disorder to identify risk genes
提高重度抑郁症基因研究的可解释性以识别风险基因
  • 批准号:
    10646326
  • 财政年份:
    2022
  • 资助金额:
    $ 79.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了